Skip to content
montabiosciences.commontabiosciences.com
  • Home
  • About us
    • Company History
    • Management
    • Board of Directors
    • Founders
  • Technology
    • Todays Challenges
    • Cancer Treatment
    • Cancer Immunotherapy
    • Development
    • References
  • News
  • Contact us
News

Granted an Investment from “Innovationsfonden”

MonTa Biosciences is part of the XVac “Grand Solutions”  granted an Investment from “Innovationsfonden”. The XVac project is a collaboration between DTU  Nanotech together with MonTa Biosciences and 3 other Companies.

Co-founder Thomas L Andresen talks in Danish national radio
Article published by the Danish Biotech media, Medwatch

MonTa Biosciences ApS

Diplomvej 381
2800 Kgs. Lyngby
Denmark

VAT nr. 36697016




    By contacting us, you agree to our privacy statement.

    Privacy statement
    MonTa Biosciences - Cancer Therapeutics of Tomorrow
    • Home
    • About us
      • Company History
      • Management
      • Board of Directors
      • Founders
    • Technology
      • Todays Challenges
      • Cancer Treatment
      • Cancer Immunotherapy
      • Development
      • References
    • News
    • Contact us